Healthcare · Active clinical trials
Despite being the world's largest pharmaceutical market, the USA recorded 12 K units active clinical trials in 2026, ranking 1st out of 197 countries. This reflects a shift toward completed studies and regulatory processes: many trials now occur in post-marketing surveillance or migrate to digital platforms. Nonetheless, American biotech hubs — from Boston to San Francisco — remain global centers for innovative therapy development.
Data for 2026 · unit: units
Position
#1 / 197
USA world ranking
Country position on the scale from last to first place for this indicator.
US
#1
#197#1
Trend
Change over time
Change in indicator over the available period.
500
1990
2 K
2000
5 K
2010
8 K
2020
12 K
2025
12 K
2026
Values — units
Comparison
Top countries by Active clinical trials
Where USA stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in USA — how much?
Based on 2026 data — 12 K units. This is rank #1 out of 197 countries.
What is USA's rank by Active clinical trials?
USA ranks #1 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in USA?
Over the available period the indicator changed from 500 to 12 K units.